Papers

2

Total Citations

14

H-Index

2

About

Cecilia Ferrari is a leading surgical oncologist whose research focuses on advancing the surgical management of pancreatic cancer through the rigorous evaluation of minimally invasive techniques. Her major contributions lie in comparing the safety and efficacy of open, laparoscopic, and robotic approaches for complex pancreatic procedures. In her highly cited 2023 study, she employed an innovative entropy balancing analysis to compare minimally invasive versus open radical antegrade modular pancreatosplenectomy (RAMPS) for pancreatic ductal adenocarcinoma, demonstrating the methodological rigor she brings to surgical outcomes research. Her most impactful work, a 2025 systematic review of randomized controlled trials comparing open, laparoscopic, and robotic pancreaticoduodenectomies, has already garnered 8 citations, highlighting the urgent clinical relevance of her findings. By synthesizing the limited available RCT evidence, Ferrari has provided crucial guidance for surgeons navigating the transition toward minimally invasive pancreatic surgery. Her work is instrumental in defining best practices for pancreatic cancer surgery, directly impacting patient recovery and oncologic outcomes.

Research Focus

Key Achievements

2
H-Index
2
Papers
14
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Comparative Analysis of Open, Laparoscopic, and Robotic Pancreaticoduodenectomy: A Systematic Review of Randomized Controlled Trials
8 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Universitat Autònoma de Barcelona, Université de Montpellier

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago